GT
DORM icon

Glenmede Trust’s Dorman Products DORM Stock Holding History

Glenmede Trust’s Portfolio DORM Stock Details DORM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Sell
2,200
-193
-8% -$23K ﹤0.01% 1253
2025
Q4 		$295K Buy
+2,393
New +$323K ﹤0.01% 1147
2025
Q1 		$296K Sell
2,458
-180
-7% -$23K ﹤0.01% 1084
2024
Q4 		$342K Buy
2,638
+135
+5% +$17.3K ﹤0.01% 1051
2024
Q3 		$283K Buy
2,503
+15
+0.6% +$1.58K ﹤0.01% 1118
2024
Q2 		$228K Buy
2,488
+355
+17% +$32.5K ﹤0.01% 1151
2024
Q1 		$206K Buy
+2,133
New +$184K ﹤0.01% 1177
2023
Q4 		– Sell
-3,331
Closed -$252K – 1308
2023
Q3 		$252K Buy
3,331
+697
+26% +$56.7K ﹤0.01% 1045
2023
Q2 		$227K Hold
2,634
– – ﹤0.01% 1066
2023
Q1 		$227K Buy
2,634
+158
+6% +$14.1K ﹤0.01% 1071
2022
Q4 		$200K Sell
2,476
-385
-13% -$32.7K ﹤0.01% 1102
2022
Q3 		$234K Buy
2,861
+706
+33% +$69.5K ﹤0.01% 1038
2022
Q2 		$236K Sell
2,155
-651
-23% -$64.5K ﹤0.01% 1060
2022
Q1 		$266K Buy
2,806
+140
+5% +$13.6K ﹤0.01% 1062
2021
Q4 		$301K Sell
2,666
-3,101
-54% -$337K ﹤0.01% 1048
2021
Q3 		$545K Sell
5,767
-1,234
-18% -$122K ﹤0.01% 885
2021
Q2 		$725K Sell
7,001
-105
-1% -$10.8K ﹤0.01% 777
2021
Q1 		$729K Sell
7,106
-271
-4% -$27K ﹤0.01% 740
2020
Q4 		$640K Sell
7,377
-293
-4% -$27.2K ﹤0.01% 786
2020
Q3 		$693K Sell
7,670
-248
-3% -$19.8K ﹤0.01% 698
2020
Q2 		$531K Buy
7,918
+1,994
+34% +$128K ﹤0.01% 753
2020
Q1 		$448K Hold
5,924
– – ﹤0.01% 932
2019
Q4 		$448K Sell
5,924
-4,008
-40% -$303K ﹤0.01% 932
2019
Q3 		$789 Buy
9,932
+673
+7% +$52.2K ﹤0.01% 786
2019
Q2 		$806 Buy
9,259
+950
+11% +$82.5K ﹤0.01% 797
2019
Q1 		$731 Buy
8,309
+77
+0.9% +$6.7K ﹤0.01% 806
2018
Q4 		$740 Buy
8,232
+1,000
+14% +$79.9K ﹤0.01% 777
2018
Q3 		$555K Buy
7,232
+980
+16% +$74.9K ﹤0.01% 870
2018
Q2 		$427K Buy
6,252
+1,736
+38% +$117K ﹤0.01% 863
2018
Q1 		$275K Hold
4,516
– – ﹤0.01% 1080
2017
Q4 		$275K Sell
4,516
-2,468
-35% -$167K ﹤0.01% 1080
2017
Q3 		$499K Sell
6,984
-3,561
-34% -$256K ﹤0.01% 905
2017
Q2 		$865K Hold
10,545
– – ﹤0.01% 792
2017
Q1 		$865K Buy
10,545
+61
+0.6% +$4.53K ﹤0.01% 792
2016
Q4 		$764K Sell
10,484
-2,422
-19% -$165K ﹤0.01% 804
2016
Q3 		$823K Sell
12,906
-217
-2% -$13.4K ﹤0.01% 790
2016
Q2 		$749K Sell
13,123
-60
-0.5% -$3.22K ﹤0.01% 809
2016
Q1 		$715K Buy
13,183
+8,954
+212% +$425K ﹤0.01% 808
2015
Q4 		$200K Hold
4,229
– – ﹤0.01% 1182
2015
Q3 		$214K Buy
4,229
+23
+0.5% +$1.15K ﹤0.01% 1160
2015
Q2 		$200K Sell
4,206
-120
-3% -$5.85K ﹤0.01% 1215
2015
Q1 		$215K Hold
4,326
– – ﹤0.01% 1222
2014
Q4 		$208K Buy
4,326
+175
+4% +$8.11K ﹤0.01% 1283
2014
Q3 		$166K Buy
4,151
+100
+2% +$4.46K ﹤0.01% 1245
2014
Q2 		$199K Buy
4,051
+142
+4% +$7.75K ﹤0.01% 1174
2014
Q1 		$230K Buy
3,909
+250
+7% +$13.7K ﹤0.01% 1128
2013
Q4 		$205K Buy
3,659
+835
+30% +$42K ﹤0.01% 1146
2013
Q3 		$139K Hold
2,824
– – ﹤0.01% 1263
2013
Q2 		$128K Buy
+2,824
New +$117K ﹤0.01% 1223

Other funds holding DORM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Glenmede Trust's DORM Position: Q1 2026 in Review

Glenmede Trust reduced its Dorman Products (DORM) stake by 8.1% in Q1 2026, selling an estimated $23K and leaving 2,200 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Glenmede Trust first reported a position in DORM in Q2 2013 and has held it in 49 quarters since. The position peaked at $865K in Q2 2017. 318 funds tracked by Wall St. Rank hold DORM as of Q1 2026.

  • Glenmede Trust held 2,200 shares of Dorman Products worth $230K as of Q1 2026.
  • Glenmede Trust sold 193 Dorman Products shares in Q1 2026, an estimated $23K.
  • Dorman Products made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1253 holding.
  • Glenmede Trust first reported a position in Dorman Products in Q2 2013 and has held it in 49 quarters since.
  • Glenmede Trust's Dorman Products position peaked at $865K in Q2 2017.
  • 318 funds tracked by Wall St. Rank held Dorman Products as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.